T4 bacteriophage nanoparticles engineered through CRISPR provide a versatile platform for rapid development of flu mucosal vaccines
Article in Antiviral Research (July 2023)
The most recent citing publication is shown below. View this citation on Dimensions.
Article in Antiviral Research (July 2023)